Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−92 JPY
−1.96 B JPY
5.59 B JPY
43.25 M
About SYMBIO PHARMACEUTICALS LTD
Sector
CEO
Fuminori Yoshida
Headquarters
Tokyo
Website
Founded
2005
ISIN
JP3383050006
FIGI
BBG0022KM682
SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded by Fuminori Yoshida on March 25, 2005 and is headquartered in Tokyo, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4582 is 199 JPY — it has increased by 3.65% in the past 24 hours. Watch SYMBIO PHARMACEUTICALS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange SYMBIO PHARMACEUTICALS LTD stocks are traded under the ticker 4582.
4582 stock has fallen by −5.24% compared to the previous week, the month change is a −19.43% fall, over the last year SYMBIO PHARMACEUTICALS LTD has showed a −19.11% decrease.
4582 reached its all-time high on May 9, 2013 with the price of 6,320 JPY, and its all-time low was 146 JPY and was reached on May 27, 2024. View more price dynamics on 4582 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4582 stock is 3.03% volatile and has beta coefficient of 0.62. Track SYMBIO PHARMACEUTICALS LTD stock price on the chart and check out the list of the most volatile stocks — is SYMBIO PHARMACEUTICALS LTD there?
Today SYMBIO PHARMACEUTICALS LTD has the market capitalization of 9.12 B, it has decreased by −3.79% over the last week.
Yes, you can track SYMBIO PHARMACEUTICALS LTD financials in yearly and quarterly reports right on TradingView.
SYMBIO PHARMACEUTICALS LTD is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
4582 net income for the last quarter is −1.30 B JPY, while the quarter before that showed −763.94 M JPY of net income which accounts for −70.65% change. Track more SYMBIO PHARMACEUTICALS LTD financial stats to get the full picture.
No, 4582 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 109.00 employees. See our rating of the largest employees — is SYMBIO PHARMACEUTICALS LTD on this list?
Like other stocks, 4582 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYMBIO PHARMACEUTICALS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SYMBIO PHARMACEUTICALS LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SYMBIO PHARMACEUTICALS LTD stock shows the sell signal. See more of SYMBIO PHARMACEUTICALS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.